Testosterone replacement therapy and prostate cancer: A word of caution

Timothy C. Brand, Edith Canby-Hagino, Ian M. Thompson

Research output: Contribution to journalReview article

Abstract

The number of men for whom testosterone is prescribed is rapidly increasing. The aging man normally demonstrates a gradual decline in testosterone. Symptoms of hypogonadism include erectile dysfunction, diminished libido, sarcopenia, increased adiposity, osteopenia and osteoporosis, impaired cognition, and depression. There is a paucity of data regarding both efficacy and safety of testosterone replacement therapy. Testosterone levels have been shown to modulate prostate cancer risk and progression. A prospective evaluation of prostate cancer risk with testosterone replacement therapy has not been conducted. We outline concerns and recommendations for the use of testosterone replacement therapy in the aging man.

Original languageEnglish (US)
Pages (from-to)11-15
Number of pages5
JournalCurrent Prostate Reports
Volume6
Issue number1
DOIs
StatePublished - Feb 1 2008

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Testosterone replacement therapy and prostate cancer: A word of caution'. Together they form a unique fingerprint.

Cite this